Surgical Science Sweden AB

49
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0014428512
SEK
34.74
1.64 (4.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
884.00
882.00
802.00
366.00
104.00
101.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
884.00
882.00
802.00
366.00
104.00
101.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
341.00
302.00
272.00
151.00
53.00
44.00
Operating Expenses
5.00
0.00
19.00
22.00
0.00
0.00
General and Administration Expenses
213.00
203.00
162.00
94.00
40.00
43.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
734.00
691.00
639.00
284.00
84.00
85.00
Operating Profit (PBDIT) excl Other Income
149.00
191.00
162.00
82.00
20.00
15.00
Other Income
14.00
77.00
70.00
34.00
-1.00
0.00
Operating Profit (PBDIT)
224.00
324.00
277.00
143.00
29.00
31.00
Interest
5.00
0.00
19.00
22.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
60.00
55.00
43.00
26.00
10.00
15.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
158.00
268.00
208.00
65.00
19.00
15.00
Provision for Tax
26.00
34.00
20.00
-20.00
4.00
2.00
Profit After Tax
131.00
233.00
187.00
86.00
15.00
12.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
2.58
4.59
3.69
2.02
0.45
0.43
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 0.14% vs 10.01% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -21.89% vs 17.46% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 765.85% vs -96.63% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is -43.73% vs 24.47% in Dec 2023

Compare Profit and Loss Results of Surgical Science Sweden AB
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
No of Months
12
12
Operating Income
884.00
898.00
-14.00
-1.56%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
884.00
898.00
-14.00
-1.56%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
341.00
274.00
67.00
24.45%
Operating Expenses
5.00
2.00
3.00
150.00%
General and Administration Expenses
213.00
601.00
-388.00
-64.56%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
734.00
751.00
-17.00
-2.26%
Operating Profit (PBDIT) excl Other Income
149.00
146.00
3.00
2.05%
Other Income
14.00
28.00
-14.00
-50.00%
Operating Profit (PBDIT)
224.00
185.00
39.00
21.08%
Interest
5.00
2.00
3.00
150.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
60.00
10.00
50.00
500.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
158.00
172.00
-14.00
-8.14%
Provision for Tax
26.00
38.00
-12.00
-31.58%
Profit After Tax
131.00
133.00
-2.00
-1.50%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.58
2.0081
0.57
28.48%
Profit And Loss - Net Sales
Net Sales 884.09 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.14% vs 10.01% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 149.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -21.89% vs 17.46% in Dec 2023

Profit And Loss - Interest
Interest 5.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 765.85% vs -96.63% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 131.65 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -43.73% vs 24.47% in Dec 2023